Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Dextrose 10% Infusion for Prevention of Postoperative Nausea and Vomiting After Emergency Laparotomy
IRCT20190325043107N74Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2026
- Countries
- 1
01
Overview
Phase 3 trial of dextrose in postoperative nausea and vomiting (PONV), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Feb 2026; status: recruiting.
02
Drugs
dextrose
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20190325043107N74.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N74.